TY - JOUR
T1 - A case of atypical benign partial epilepsy with action myoclonus
AU - Kobayashi, Satoru
AU - Inui, Takehiko
AU - Wakusawa, Keisuke
AU - Tanaka, Soichiro
AU - Nakayama, Tojo
AU - Uematsu, Mitsugu
AU - Takayanagi, Masaru
AU - Yamamoto, Toshiyuki
AU - Haginoya, Kazuhiro
PY - 2013/4
Y1 - 2013/4
N2 - We describe a boy, 3 years and 6 months old, who experienced a rolandic seizure accompanied by a cluster of atypical absence seizures, the EEGs for which corresponded to those of atypical benign partial epilepsy (ABPE). Of note, this patient suffered from developmental delay beginning in infancy and exhibited giant middle-latency somatosensory evoked potentials with action myoclonus. With the exceptions of ethosuximide, acetazolamide, and adrenocorticotropic hormone, which have been reported to be effective in ABPE, the atypical absence seizures were intractable despite extensive treatment with various anticonvulsants. The drugs that were effective led to a remarkable reduction in seizure frequency and EEG improvement, but the efficacy was temporary. The patient demonstrated moderate mental retardation without regression and could not walk with support or speak any meaningful words at the age of 3 years and 6 months. Based on thorough differential diagnosis, although further studies will be necessary, we propose that this boy may present a new phenotype of ABPE: ABPE with action myoclonus.
AB - We describe a boy, 3 years and 6 months old, who experienced a rolandic seizure accompanied by a cluster of atypical absence seizures, the EEGs for which corresponded to those of atypical benign partial epilepsy (ABPE). Of note, this patient suffered from developmental delay beginning in infancy and exhibited giant middle-latency somatosensory evoked potentials with action myoclonus. With the exceptions of ethosuximide, acetazolamide, and adrenocorticotropic hormone, which have been reported to be effective in ABPE, the atypical absence seizures were intractable despite extensive treatment with various anticonvulsants. The drugs that were effective led to a remarkable reduction in seizure frequency and EEG improvement, but the efficacy was temporary. The patient demonstrated moderate mental retardation without regression and could not walk with support or speak any meaningful words at the age of 3 years and 6 months. Based on thorough differential diagnosis, although further studies will be necessary, we propose that this boy may present a new phenotype of ABPE: ABPE with action myoclonus.
KW - Action myoclonus
KW - Atypical benign partial epilepsy
KW - Electroencephalogram
UR - http://www.scopus.com/inward/record.url?scp=84875213502&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875213502&partnerID=8YFLogxK
U2 - 10.1016/j.seizure.2012.12.003
DO - 10.1016/j.seizure.2012.12.003
M3 - Article
C2 - 23280272
AN - SCOPUS:84875213502
SN - 1059-1311
VL - 22
SP - 242
EP - 245
JO - Seizure : the journal of the British Epilepsy Association
JF - Seizure : the journal of the British Epilepsy Association
IS - 3
ER -